Jan‐Peter Glossmann

508 total citations
18 papers, 339 citations indexed

About

Jan‐Peter Glossmann is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Jan‐Peter Glossmann has authored 18 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 7 papers in Oncology and 4 papers in Genetics. Recurrent topics in Jan‐Peter Glossmann's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Jan‐Peter Glossmann is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Jan‐Peter Glossmann collaborates with scholars based in Germany, Austria and United States. Jan‐Peter Glossmann's co-authors include Volker Diehl, Andreas Josting, Raymond Voltz, Michael Hallek, Juergen Wolf, Jan Gaertner, Andreas Engert, Lucia Nogová, Thomas Schober and Jeremy Franklin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cochrane Database of Systematic Reviews.

In The Last Decade

Jan‐Peter Glossmann

17 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan‐Peter Glossmann Germany	10	179	167	106	92	64	18	339
Kai Breuer Germany	8	204 1.1×	203 1.2×	258 2.4×	70 0.8×	73 1.1×	12	520
Ulla Martinsson Sweden	10	92 0.5×	85 0.5×	79 0.7×	24 0.3×	97 1.5×	24	302
Bente Arboe Denmark	7	123 0.7×	202 1.2×	40 0.4×	60 0.7×	13 0.2×	12	279
Giacomo Loseto Italy	11	158 0.9×	87 0.5×	52 0.5×	29 0.3×	38 0.6×	24	343
Djamila E. Issa Netherlands	9	201 1.1×	135 0.8×	41 0.4×	43 0.5×	78 1.2×	22	274
Melissa M. Hudson United States	11	94 0.5×	116 0.7×	175 1.7×	77 0.8×	178 2.8×	20	429
Erica Linden United States	8	116 0.6×	101 0.6×	82 0.8×	30 0.3×	25 0.4×	12	374
Christine Laidlaw Australia	11	157 0.9×	119 0.7×	63 0.6×	52 0.6×	11 0.2×	21	353
Anita J. Kumar United States	11	95 0.5×	60 0.4×	74 0.7×	30 0.3×	47 0.7×	37	245
L. Casanova Peru	7	193 1.1×	132 0.8×	58 0.5×	47 0.5×	20 0.3×	12	314

Countries citing papers authored by Jan‐Peter Glossmann

Since Specialization

Citations

This map shows the geographic impact of Jan‐Peter Glossmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Peter Glossmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Peter Glossmann more than expected).

Fields of papers citing papers by Jan‐Peter Glossmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan‐Peter Glossmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Peter Glossmann. The network helps show where Jan‐Peter Glossmann may publish in the future.

Co-authorship network of co-authors of Jan‐Peter Glossmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jan‐Peter Glossmann. A scholar is included among the top collaborators of Jan‐Peter Glossmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan‐Peter Glossmann. Jan‐Peter Glossmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Glossmann, Jan‐Peter, et al.. (2018). Konjunktivales Melanom. Der Ophthalmologe. 115(6). 489–498. 9 indexed citations

Gartlehner, Gerald, Ina Monsef, Philipp Dahm, et al.. (2018). Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer). Cochrane Database of Systematic Reviews. 2018(7). CD012556–CD012556. 20 indexed citations

Skoetz, Nicole, Gerald Gartlehner, Ina Monsef, et al.. (2017). Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer). Cochrane Database of Systematic Reviews. 4 indexed citations

Kron, Florian, Nadine Kutsch, Jan‐Peter Glossmann, et al.. (2016). Economic evaluation of chronic lymphocytic leukemia from a hospital management perspective. European Journal Of Haematology. 98(2). 169–176. 1 indexed citations

Glossmann, Jan‐Peter, et al.. (2015). Angewandtes Case Management. 1 indexed citations

Gaertner, Jan, Juergen Wolf, Sebastian Frechen, et al.. (2011). Recommending early integration of palliative care — does it work?. Supportive Care in Cancer. 20(3). 507–513. 34 indexed citations

Gaertner, Jan, Juergen Wolf, Michael Hallek, Jan‐Peter Glossmann, & Raymond Voltz. (2011). Standardizing integration of palliative care into comprehensive cancer therapy—a disease specific approach. Supportive Care in Cancer. 19(7). 1037–1043. 53 indexed citations

Gaertner, Jan, Juergen Wolf, Christoph Ostgathe, et al.. (2010). Specifying WHO Recommendation: Moving toward Disease-Specific Guidelines. Journal of Palliative Medicine. 13(10). 1273–1276. 20 indexed citations

Sieniawski, Michal, Jeremy Franklin, Lucia Nogová, et al.. (2007). Outcome of Patients Experiencing Progression or Relapse After Primary Treatment With Two Cycles of Chemotherapy and Radiotherapy for Early-Stage Favorable Hodgkin's Lymphoma. Journal of Clinical Oncology. 25(15). 2000–2005. 37 indexed citations

10.

Sieniawski, Michal, Oliver Staak, Jan‐Peter Glossmann, et al.. (2006). Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma. Annals of Hematology. 86(2). 107–115. 24 indexed citations

11.

Glossmann, Jan‐Peter, Jan Oliver Staak, Lucia Nogová, et al.. (2005). Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma. Annals of Hematology. 84(8). 517–525. 9 indexed citations

12.

Josting, Andreas, Lucia Nogová, Jeremy Franklin, et al.. (2005). Salvage Radiotherapy in Patients With Relapsed and Refractory Hodgkin’s Lymphoma: A Retrospective Analysis From the German Hodgkin Lymphoma Study Group. Journal of Clinical Oncology. 23(7). 1522–1529. 86 indexed citations

13.

Josting, Andreas, Christian Rudolph, Markus Y. Mapara, et al.. (2004). Cologne High-Dose Sequential Chemotherapy in Relapsed and Refractory Hodgkin Lymphoma - Results of a Large Multicenter Study of the German Hodgkin Lymphoma Study Group (GHSG).. Blood. 104(11). 309–309. 4 indexed citations

14.

Glossmann, Jan‐Peter, Jan Oliver Staak, Claudia Wickenhauser, Volker Diehl, & Andreas Josting. (2003). Extramedullar Acute Myeloid Leukemia (Granulocytic Sarcoma) with Arm Paresis, Maculopapular Exanthema and Organ Involvement. Leukemia & lymphoma. 44(9). 1619–1621. 10 indexed citations

15.

Glossmann, Jan‐Peter, Jan Oliver Staak, Claudia Wickenhauser, Volker Diehl, & Andreas Josting. (2003). Extramedullary Acute Myeloid Leukemia (Granulocytic Sarcoma) with Arm Paresis, Maculopapular Exanthema and Organ Involvement. Leukemia & lymphoma. 44(9). 1619–1621. 10 indexed citations

16.

Glossmann, Jan‐Peter, Andreas Josting, & Volker Diehl. (2002). New treatments for Hodgkin’s disease. Current Treatment Options in Oncology. 3(4). 283–290. 15 indexed citations

17.

Staak, Jan Oliver, Jan‐Peter Glossmann, Volker Diehl, & Andreas Josting. (2002). Hepatitis-C-Virus-assoziierte Kryoglobulinämie. Medizinische Klinik. 97(10). 601–608. 1 indexed citations

18.

Glossmann, Jan‐Peter, et al.. (2000). "Lean Management" im ärztlichen Bereich. Medizinische Klinik. 95(8). 470–473. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact